Detail akcie C-Rad -B- online

Business Summary: C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
Financial Summary: BRIEF: For the nine months ended 30 September 2019, C-Rad AB revenues increased 17% to SEK154.4M. Net loss decreased 50% to SEK1.5M. Revenues reflect APAC segment increase of 49% to SEK44.7M, North America segment increase of 13% to SEK36.3M, EMEA segment increase of 5% to SEK73.4M. Lower net loss reflects Positioning external sales segment income totaling SEK8.5M vs. loss of SEK600K.